Harvest Fund Management Co. Ltd grew its position in shares of AvePoint, Inc. (NASDAQ:AVPT – Free Report) by 43,182.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,149 shares of the company’s stock after acquiring an additional 15,114 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in AvePoint were worth $250,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently bought and sold shares of the company. Quantbot Technologies LP boosted its holdings in AvePoint by 142.8% during the 3rd quarter. Quantbot Technologies LP now owns 153,747 shares of the company’s stock worth $1,810,000 after acquiring an additional 90,413 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of AvePoint by 8.3% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 70,013 shares of the company’s stock worth $824,000 after purchasing an additional 5,352 shares during the period. Walleye Capital LLC bought a new stake in shares of AvePoint during the 3rd quarter worth $2,970,000. Charles Schwab Investment Management Inc. raised its stake in shares of AvePoint by 7.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 897,584 shares of the company’s stock worth $10,565,000 after purchasing an additional 63,323 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of AvePoint by 13.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,536,660 shares of the company’s stock worth $18,086,000 after purchasing an additional 184,361 shares during the period. 44.49% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on the company. William Blair reiterated an “outperform” rating on shares of AvePoint in a research note on Tuesday, March 4th. Citigroup lowered their target price on AvePoint from $18.00 to $16.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 11th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $15.75.
AvePoint Stock Performance
Shares of AvePoint stock opened at $15.05 on Friday. AvePoint, Inc. has a 52-week low of $7.52 and a 52-week high of $19.90. The stock’s 50-day simple moving average is $17.10 and its 200 day simple moving average is $15.49. The stock has a market capitalization of $3.04 billion, a P/E ratio of -300.94 and a beta of 1.11.
AvePoint Profile
AvePoint, Inc provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services.
Featured Articles
- Five stocks we like better than AvePoint
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Want to Profit on the Downtrend? Downtrends, Explained.
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What is Short Interest? How to Use It
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding AVPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AvePoint, Inc. (NASDAQ:AVPT – Free Report).
Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.